US Patent 9314449 Methods of treating pediatric patients using dexmedetomidine
Patent 9314449 was granted and assigned to Hospira on April, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+492 characters)
Article
Patent abstract
The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.
Edits on 12 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09314449 Methods of treating pediatric patients using dexmedetomidine US Patent 9314449 Methods of treating pediatric patients using dexmedetomidine
Infobox
Patent Number
0931444900
Patent Number
931444900
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093144490
Date of Patent
April 19, 2016
0Patent Application Number
137264960
Date Filed
December 24, 2012
0Official Website
Patent Primary Examiner
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093144490
Date of Patent
April 19, 2016
0Patent Application Number
137264960
Date Filed
December 24, 2012
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09314449 Methods of treating pediatric patients using dexmedetomidine
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09314449
Date of patent
April 19, 2016
Patent application number
13726496
Date Filed
December 24, 2012
Patent primary examiner
Find more entities like US Patent 9314449 Methods of treating pediatric patients using dexmedetomidine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
